Chronic airway diseases
PG14 Postgraduate Course
Smoking cessation in patients with respiratory diseases
Clinical
Smoking prevention and cessation (HLfL)
Registration for this session is additional to the congress registration fee and is €171 on site, €153 standard.
Aims : This course will: (1) provide respiratory professionals with smoking cessation knowledge and tools to apply in their everyday practice, (2) provide an update on smoking cessation guidelines; (3) raise awareness of the positive impact of smoking cessation measures in the treatment of lung diseases; and (4) explain the specific factors to take into account when treating specific groups of patients.
Target audience :
Allergologist, Allied health professional, Cardiologist, Clinician, Educationalist, Epidemiologist, Fellow, General practitioner, Junior member, Nurse, Occupational therapist, Oncologist, Patient, Physiotherapist, Psychologist, Public health official, Pulmonologist, Researcher, Resident, Respiratory physician, Respiratory therapist, Student, Trainee
14:00
Behavioural counselling for smoking cessation in respiratory patients and other interventions to reduce harm
D. Fotopoulos(Nicosia, Cyprus)
COI
1
207
14:30
Smoking cessation in COPD patients (with comorbidities)
C. Jimenez Ruiz(Madrid, Spain)
COI
-
Description
2
208
15:00
Group assignment
3
209
16:00
Smoking cessation in lung cancer patients
K. Lewis(Llanelli (Dyfed), United Kingdom)
COI
-
Description
5
211
16:30
Smoking cessation in asthma patients
P. Katsaounou(Athens, Greece)
COI
D. Candlish(Nantwich (Cheshire), United Kingdom)
COI
-
Description
6
212
17:00
Group assignment
7
213
. . .